Literature DB >> 16769535

Self-expanding metallic stent as a bridge to surgery versus emergency resection for obstructing left-sided colorectal cancer: a case-matched study.

Ka Chun Ng1, Wai Lun Law, Yee Man Lee, Hok Kwok Choi, Chi Leung Seto, Judy W C Ho.   

Abstract

This study aimed to compare the outcomes of patients who suffered from obstructing left-sided colorectal cancer, treated with self-expanding metallic stent (SEMS) as a bridge to surgery, with those who underwent emergency operation. Twenty patients who had acute obstruction due to left-sided colorectal cancer underwent surgical resection after insertion of SEMS (group I) were matched to 40 patients with emergency colonic resection (group II). The two groups were compared for the incidence of primary anastomosis, stoma rate, hospital stay, duration of intensive care, postoperative morbidity, and mortality. Both groups had similar preoperative comorbidity and stage of disease, but the tumors in group I were more distally located (P < 0.001). In group I, one patient developed colon perforation and required Hartmann's operation. All the other patients underwent elective operation with primary anastomosis. In group II, primary anastomosis was performed in 29 patients (72.5%; P = 0.047). The operative mortality of group I and group II was 5% and 12.5%, respectively (P = 0.653). Significantly shorter median postoperative hospital stay and median stay in the intensive care unit (ICU) were observed in group I (9 days [range, 5-39 days] vs. 12 days [range, 8-49 days], P = 0.015 and 0 day [range, 0-17 days] vs. 0.5 day [range, 0-18 days], P = 0.022, respectively). There were no differences in hospital mortality (P = 0.653) or 30-day mortality (P = 0.653). Both groups had similar reoperation rates, surgical complications, and medical complications. When compared with emergency resection, insertion of SEMS as a bridge to surgery for obstructing left-sided colorectal cancer is associated with a higher rate of primary anastomosis as well as a better outcome in terms of hospital stay and stay in the ICU. The wider application of this treatment option for obstructing colorectal cancer warranted further studies.

Entities:  

Mesh:

Year:  2006        PMID: 16769535     DOI: 10.1016/j.gassur.2006.02.006

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  32 in total

1.  Multivariate analysis of morbidity and mortality from the initial surgical management of obstructing carcinoma of the colon.

Authors:  I M Leitman; J D Sullivan; D Brams; J J DeCosse
Journal:  Surg Gynecol Obstet       Date:  1992-06

2.  Emergency surgery for obstructing colorectal cancers: a comparison between right-sided and left-sided lesions.

Authors:  Y M Lee; W L Law; K W Chu; R T Poon
Journal:  J Am Coll Surg       Date:  2001-06       Impact factor: 6.113

3.  Intra-operative colonic irrigation in the management of left-sided large bowel emergencies.

Authors:  N M Koruth; Z H Krukowski; G G Youngson; W S Hendry; J R Logie; P F Jones; A Munro
Journal:  Br J Surg       Date:  1985-09       Impact factor: 6.939

4.  Large bowel obstruction: predictive factors for postoperative mortality.

Authors:  Sebastiano Biondo; David Parés; Ricardo Frago; Joan Martí-Ragué; Esther Kreisler; Javier De Oca; Eduardo Jaurrieta
Journal:  Dis Colon Rectum       Date:  2004-11       Impact factor: 4.585

5.  The role of one-stage surgery in acute left-sided colonic obstruction.

Authors:  P W Lau; C Y Lo; W L Law
Journal:  Am J Surg       Date:  1995-04       Impact factor: 2.565

6.  A comparison of laparoscopically assisted and open colectomy for colon cancer.

Authors:  Heidi Nelson; Daniel J Sargent; H Sam Wieand; James Fleshman; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; David Ota
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

7.  Palliative treatment of malignant colorectal strictures with metallic stents.

Authors:  L Paúl Díaz; I Pinto Pabón; R Fernández Lobato; C Montes López
Journal:  Cardiovasc Intervent Radiol       Date:  1999-01       Impact factor: 2.740

Review 8.  Malignant obstruction of the left colon.

Authors:  G T Deans; Z H Krukowski; S T Irwin
Journal:  Br J Surg       Date:  1994-09       Impact factor: 6.939

Review 9.  Systematic review of the efficacy and safety of colorectal stents.

Authors:  U P Khot; A Wenk Lang; K Murali; M C Parker
Journal:  Br J Surg       Date:  2002-09       Impact factor: 6.939

10.  Self-expandable stent before elective surgery vs. emergency surgery for the treatment of malignant colorectal obstructions: comparison of primary anastomosis and morbidity rates.

Authors:  Cristina Martinez-Santos; Rosa F Lobato; José Manuel Fradejas; Isabel Pinto; Pablo Ortega-Deballón; Mariano Moreno-Azcoita
Journal:  Dis Colon Rectum       Date:  2002-03       Impact factor: 4.585

View more
  32 in total

1.  Guidelenines in the management of obstructing cancer of the left colon: consensus conference of the world society of emergency surgery (WSES) and peritoneum and surgery (PnS) society.

Authors:  Luca Ansaloni; Roland E Andersson; Franco Bazzoli; Fausto Catena; Vincenzo Cennamo; Salomone Di Saverio; Lorenzo Fuccio; Hans Jeekel; Ari Leppäniemi; Ernest Moore; Antonio D Pinna; Michele Pisano; Alessandro Repici; Paul H Sugarbaker; Jean-Jaques Tuech
Journal:  World J Emerg Surg       Date:  2010-12-28       Impact factor: 5.469

2.  Preoperative colonic stents versus emergency surgery for acute left-sided malignant colonic obstruction: a meta-analysis.

Authors:  Xuan Huang; Bin Lv; Shuo Zhang; Lina Meng
Journal:  J Gastrointest Surg       Date:  2013-10-30       Impact factor: 3.452

3.  Colonic self-expanding metal stent (SEMS) as a bridge to surgery in left-sided malignant colonic obstruction: an 8-year review.

Authors:  Kit-Man Ho; Ka-Man Chan; Shu-Yan Kwok; Patrick Ying-Yu Lau
Journal:  Surg Endosc       Date:  2016-09-08       Impact factor: 4.584

Review 4.  Emergency management of malignant acute left-sided colonic obstruction.

Authors:  Vasileios Trompetas
Journal:  Ann R Coll Surg Engl       Date:  2008-04       Impact factor: 1.891

5.  Colonic perforation either during or after stent insertion as a bridge to surgery for malignant colorectal obstruction increases the risk of peritoneal seeding.

Authors:  Su Jin Kim; Hyung Wook Kim; Su Bum Park; Dae Hwan Kang; Cheol Woong Choi; Byeong Jun Song; Joung Boom Hong; Dong Jun Kim; Byung Soo Park; Gyung Mo Son
Journal:  Surg Endosc       Date:  2015-02-13       Impact factor: 4.584

Review 6.  Colonic stenting vs emergent surgery for acute left-sided malignant colonic obstruction: a systematic review and meta-analysis.

Authors:  Guang-Yao Ye; Zhe Cui; Lu Chen; Ming Zhong
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

7.  A prospective evaluation of short-term and long-term results from colonic stenting for palliation or as a bridge to elective operation versus immediate surgery for large-bowel obstruction.

Authors:  Luca Gianotti; Nicolò Tamini; Luca Nespoli; Matteo Rota; Elisa Bolzonaro; Roberto Frego; Alessandro Redaelli; Laura Antolini; Antonella Ardito; Angelo Nespoli; Marco Dinelli
Journal:  Surg Endosc       Date:  2012-10-06       Impact factor: 4.584

8.  Primary colon resection or Hartmann's procedure in malignant left-sided large bowel obstruction? The use of stents as a bridge to surgery.

Authors:  Reinhart T Grundmann
Journal:  World J Gastrointest Surg       Date:  2013-01-27

9.  A novel anchoring system for colonic stents: a pilot in vivo study in a porcine model.

Authors:  A Nevler; U Willantz; O Doron; J Sandbank; Y Ziv
Journal:  Tech Coloproctol       Date:  2013-11-28       Impact factor: 3.781

10.  Meta-analysis of randomized trials comparing endoscopic stenting and surgical decompression for colorectal cancer obstruction.

Authors:  Vincenzo Cennamo; Carmelo Luigiano; Federico Coccolini; Carlo Fabbri; Marco Bassi; Giuseppe De Caro; Liza Ceroni; Antonella Maimone; Paolo Ravelli; Luca Ansaloni
Journal:  Int J Colorectal Dis       Date:  2012-11-15       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.